Show 921: Pushing the Envelope on Prostate Cancer Diagnosis and Treatment

This year more than 200,000 men will get a diagnosis of prostate cancer, and about 30,000 men will die of the disease. Screening for prostate cancer with the PSA test has become quite controversial, because so many of the cancers identified would not cause trouble. The most common treatments for prostate cancer may cause men trouble, though, including incontinence and impotence.

There are a number of new approaches that are not well known. Find out why MRIs and focal therapies should be on the radar screen of most men who have received this frightening diagnosis. Why isn’t immediate surgical removal of the prostate gland always the best treatment? Our guests present cutting edge information that could save men from a lot of pain and suffering.

The Guests:

Jay Cohen, MD, is an expert on prescription medications and natural supplements. He has written several books, including Overdose: The Case Against the Drug Companies. His latest book is Prostate Cancer Breakthroughs: New Tests, New Treatments, Better Options. The photo is of Dr. Cohen.

Cary Robertson, M.D., is an associate professor in the Division of Urology at Duke University Medical Center in Durham, N.C. A board-certified urologist, Dr. Robertson is the director of the Morris Center for Urologic Research at the Duke Cancer Institute and is a leading expert on prostate cancer and its treatments. He is the author of the book Prostate Cancer: A Guide for Men.

Thomas J. Polascik, M.D., F.A.C.S., is Professor of Surgery and Director of the Society of Urologic Oncology program at Duke University Medical Center. He is also Director of the Genitourinary program on Focal Therapy at _Duke Cancer Institute. Dr. Polascik is the founder and director of The International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer and Past President of the North Carolina Urological Association. He is editor of the medical book, Imaging and Focal Therapy of Early Prostate Cancer.